FDA
approval
· 2023-03-06
FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Original Application (Par Health USA, LLC)
Summary
FDA approved an original ANDA for a generic fixed-dose combination of bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride (Par Health USA…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE)